Alessio Cirillo | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey	TUMORI	2024
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis	BMC CANCER	2024
The role of CD73 in predicting the response to immunotherapy in head and neck cancer patients	PATHOLOGY RESEARCH AND PRACTICE	2024
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis	BMC CANCER	2024
Correction to: Clinical impact of drug-drug interactions on abemaciclib in the real-world experience of AB-ITALY study (npj Breast Cancer, (2024), 10, 1, (58), 10.1038/s41523-024-00657-z)	NPJ BREAST CANCER	2024
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature	CANCERS	2024
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach	CANCER IMMUNOLOGY, IMMUNOTHERAPY	2023
Circulating CD137+ T cell levels are correlated with response to pembrolizumab treatment in advanced head and neck cancer patients	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2023
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey	TUMORI	2023
Rheumatic Diseases Development in Patients Treated by Anti-PD1 Immune Checkpoint Inhibitors: A Single-Centre Descriptive Study	LIFE	2023
Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study	FRONTIERS IN ONCOLOGY	2023
Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study	FRONTIERS IN ONCOLOGY	2023
The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature	FRONTIERS IN ONCOLOGY	2022
Renal function outcomes in metastatic non-small-cell lung carcinoma patients treated with chemotherapy or immune checkpoint inhibitors: an unexpected scenario	VACCINES	2022
Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up	DIAGNOSTICS	2022
Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up	DIAGNOSTICS	2022
Genomic and immune approach in platinum refractory HPV-negative head and neck squamous cell carcinoma patients treated with Immunotherapy: a novel combined profile	BIOMEDICINES	2022
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy	FRONTIERS IN IMMUNOLOGY	2022
Oral immune-related adverse events associated with PD-1 inhibitor treatment: a case series	APPLIED SCIENCES	2022
DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients	ANNALS OF ONCOLOGY	2022